Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
WST
WST
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
WST News
McKesson Reports Strong Q3 Fiscal 2026 Results Driven by Specialty Growth
Mar 20 2026
NASDAQ.COM
Analysis of Risks in Overvalued Stocks
Mar 19 2026
Yahoo Finance
Companies Like Monster, Palantir, and Expedia That Can Withstand Market Turbulence
Mar 12 2026
Barron's
Stocks Like Monster Beverage and Expedia Poised to Endure Market Fluctuations with Higher Profit Margins.
Mar 12 2026
Barron's
Market Capitalization Comparison: West Pharmaceutical vs. Viatris
Mar 12 2026
NASDAQ.COM
Hims & Hers Shares Rise, BioNTech Crashes Amid Leadership Changes
Mar 10 2026
CNBC
Centene Shares Drop 7.7%, Worst Performer in S&P 500 Today
Mar 10 2026
NASDAQ.COM
West Pharmaceutical CEO Eric Green Plans Retirement, Transition Expected by 2026
Mar 10 2026
NASDAQ.COM
West Pharmaceutical CEO Eric Green Plans Retirement After Succession
Mar 09 2026
seekingalpha
West Pharmaceutical CEO Eric Green Announces Retirement
Mar 09 2026
PRnewswire
West Pharmaceutical CEO Eric Green Announces Retirement Plans
Mar 09 2026
Newsfilter
West Pharmaceutical Services Announces Upcoming Investor Conferences
Feb 27 2026
PRnewswire
West Pharmaceutical Services Announces Upcoming Investor Conferences
Feb 27 2026
Newsfilter
Eli Lilly's Dominance in Obesity Drug Market Reinforced
Feb 23 2026
CNBC
West Pharmaceutical Services Authorizes $1B Share Repurchase Program
Feb 17 2026
seekingalpha
West Pharmaceutical Declares Quarterly Dividend and Share Repurchase Program
Feb 17 2026
Yahoo Finance
Show More News